Better understanding alveolarization mechanisms could help improve prevention and treatment of diseases characterized by reduced alveolar number. Although signaling through fibroblast growth factor (FGF) receptors is essential for alveolarization, involved ligands are unidentified. FGF18, the expression of which peaks coincidentally with alveolar septation, is likely to be involved. Herein, a mouse model with inducible, lung-targeted FGF18-transgene was used to advance the onset of FGF18 expression peak, and genome-wide expression changes were determined by comparison with littermate controls. Quantitative RT-PCR was used to confirm expression changes of selected up and down regulated genes, and to determine their expression profiles in the course of lung postnatal development. This allowed identifying so far unknown target genes of the factor, among which a number are known to be involved in alveolarization. The major target was adrenomedullin, a promoter of lung angiogenesis and alveolar development, whose transcript was increased 6.9-fold. Other genes involved in angiogenesis presented marked expression increases, including Wnt2 and cullin2.
INTRODUCTION

28
Lung alveolarization, the formation process of definitive alveoli, is a complex developmental event 29 that extends from the last gestational weeks to the 2 first postnatal years. In rats and mice that are 30 classical model animals for studying its underlying mechanisms, it is entirely postnatal; subdivision of 31 alveolar sacs by secondary septation takes place between days 4 and 14 (although recent investigations 32 have indicated that new alveoli can be generated later from mature septa), and septal maturation with 33 fusion of double capillary layer into a single layer is terminated on day 20. Alveolarization involves a 34 variety of regulatory factors, but its control is only partially understood (5) . Deciphering these 35 mechanisms is of particular importance because they are profoundly disturbed in chronic lung disease 36 of the premature neonate also known as "new" bronchopulmonary dysplasia (BPD) (19) or in lung 37 hypoplasia consecutive to congenital diaphragmatic hernia (CDH) (3) . Furthermore, maintenance of 38 alveolar structure necessitates the persistence of at least some of these control pathways in the adult 39 lung, which appears to be disordered in emphysema (6).
40
Alveolarization is abolished in mice simultaneously devoid of fibroblast growth factor (FGF) 41 receptors (FGFR) 3 and 4 (49). Despite normal elastic fiber gene expression in isolated lung interstitial 42 cells, excessive elastin deposition occurs in this model with loss of typical spatial restriction, and 43 epithelial cells contribute to the observed abnormalities (42). Thus far however, the identity of 44 involved FGF(s) has remained elusive. The assumption that FGF18 is involved is based on the facts 45 that (i) this mediator, similar to the most homologous other FGF-family members FGF8 and FGF17, 46 binds FGFR4 and the IIIc-form of FGFR3 with high affinity (12, 39) , and (ii) a strong rise of FGF18 47 expression occurs when secondary septation starts in 3 species, namely the rat (7), the mouse (8, 30) 48 and man (3). Most strikingly, secondary septation coincides precisely with the peak of lung FGF18 49 expression that falls abruptly after its ending in the rat and the mouse (7, 8, 30) . Indeed, FGF18 level 50 could not be studied until completion of alveolar development in man because this occurs during the 51 second postnatal year.
52
Although it is expressed at a lower rate earlier, there are evidences for FGF18 involvement in 53 previous lung developmental stages already. Conditional expression of FGF18 in the lung of 54 transgenic mouse fetuses from embryonic day 6 to term thus caused distal airways to adopt structural 55 features of proximal airways with abnormal cartilage deposition, suggesting a role in the control of 56 proximal differentiation program during pseudoglandular/canalicular stages (51) . FGF18 was 57 accordingly reported to control chondrogenesis in upper airways (11). These findings, however, do not 58 enlighten the functional significance of the marked postnatal peak of FGF18 expression, when the 59 tract of cartilage-containing conducting airways is complete. Another investigation evidenced reduced 60 air space, thicker interstitial mesenchymal compartments, and presence of embedded capillaries in the 61 prenatal lung consequently to Fgf18 gene targeting in mice, which indicates involvement at saccular 62 stage also (45) . Consistently, FGF18 expression was found to be enhanced in the stimulation of fetal 63 rat lung growth induced by tracheal ligation (34) . Unfortunately, FGF18 gene targeting cannot be used 64 to investigate FGF18 role during alveolar stage because Fgf18 -/pups do not survive beyond birth.
65
Although FGF18 implication in alveolarization has therefore not yet received demonstration, it is 66 nevertheless further supported indirectly by several observations. Thus, FGF18 stimulated ex vivo 67 proliferation of perinatal rat lung fibroblasts and enhanced their expression of elastic fiber components 68 (7) , two events that occur during alveolar septation. Last, although FGF18 is unexplored in BPD, 69 decreased FGF18 expression was found to be associated with impaired alveolarization in 2 instances, 70 (i) a rat model of BPD (28) and (ii) human lung hypoplasia consecutive to CDH (3).
71
To document the molecular effects of FGF18 and try to explore the physiological significance of its 72 sharp postnatal expression peak, the Tet-On system-based mouse model of conditional FGF18 73 expression in the lung designed by Whitsett et al. (51) was used here to provoke a rise of FGF18 in the 74 perinatal period, hence inducing precociously an increase of expression similar to the one occurring 75 after birth during secondary alveolar septation. Pups were collected before the onset of septation, i.e. 76 before the rise of endogenous FGF18. This timing was chosen because we assumed that inducing the 77 expression of the transgene later, during the stage of secondary septation, might have added little to 78 the effects of endogenous FGF18-gene expression. In view of the considerable rise of the latter during 79 this stage, responses are likely to be high, and even possibly maximal. Gene profiling study was then 80 performed on genome-wide expression microarrays to identify genes up or down regulated by induced 81 FGF18 expression. Double transgenic mouse pups bearing both the inducible FGF18 transgene and 82 the inducer construct were compared to controls bearing only the silent FGF18 transgene. Some of the 83 affected genes were selected on the basis of both their known functions and the extent of FGF18 84 effects to confirm changes by quantitative RT-PCR and to determine their expression profile during 85 postnatal development. We thus identified as FGF18 targets a variety of genes the involvement of 86 which in alveolarization is either demonstrated or likely, which argues for specific FGF18 functions in 87 postnatal lung development.
89
MATERIAL AND METHODS
90
Wild type mice, transgenic mice and treatments 91 Wild type FVB/N mice were purchased from Charles River Laboratories (Saint Germain sur 92 l'Arbresle, France). The transgenic mouse model has been described in detail previously (45). In brief, 93 mice bearing the inducible construct (teto) 7 -CMV-FGF18 transgene were bred to SP-C-rtTA mice in 94 which the expression of the rtTA activator construct is targeted on alveolar epithelial type II cells by 95 the promoter of surfactant protein C. Mice bearing the transgenic constructs were bred in an FVB/N 96 background from two male founders obtained from the Cincinnati Children's Research Foundation.
97
Animal experiments were performed under license from the Animal Health and Protection Service of 98 the French Ministry of Agriculture. Because FGF18 expression in mouse lung increases postnatally to 99 peak on days 7 to 10 (8, 30), the inducer doxycycline was given from prenatal day 2 (E18) to postnatal 100 day 2 (P2) in order to induce earlier an expression peak similar to the one occurring during alveolar 101 septation. Pup lungs were collected aseptically on P3 under pentobarbital anesthesia and kept frozen at 102 -80°C until use or fixed at constant pressure for histological analysis. Experimental protocol is 103 summarized in Fig.1 .
105
Lung morphology and morphometry 106 Methods used in this study have been described in detail previously (28). Briefly, lung fixation was 107 performed by tracheal infusion of neutral buffered paraformaldehyde at constant 20cm H 2 O pressure, 108 and fixed lung volume was measured by fluid displacement. After routine processing and paraffin 109 embedding, 4-µm-thick mediofrontal sections through both lungs were stained with picro-indigo-110 carmine for morphological pictures or with hematoxylin-phloxine-saffron for morphometry. Alveolar airspace, airways, blood vessels larger than 20 µm in diameter, interstitial tissue volume densities and 112 the alveolar surface density were determined using the point counting and mean linear intercept 113 methods (48). Light microscope fields were quantified at an overall magnification of x440 on 20 fields 114 per animal (10 per lung) with a systematic sampling method from a random starting point. All 115 morphometric analyses were performed by a single observer (BCH) who was unaware of group 116 assignment.
118
Genotyping and assessment of FGF18-transgene expression
119
Genotyping was performed on DNA extracted from mouse-tails by use of the ChargesSwitch® gDNA 120 kit Mini Tissue kit from Invitrogen (Cergy-Pontoise, France) using the following primers for PCR in a 121 Hybaid thermocycler: for SP-C-rtTA, 5'-GACACATATAAGACCTGGTC-3' (forward) and (5'-122 AAAATCTTGCCAGRCTTCCCC-3' (reverse); for (teto) 7 -FGF18, 5'-GCCATCCACGCTCTTTG-3' 123 (forward primer located in the CMV minimal promoter) and 5'-124 CAGGACTTGAATGTGCTTCCCACTG-3' (reverse primer located in the FGF18 cDNA). The two 125 last primers were also used in doxycycline-treated pups to assess specifically the FGF18-transgene 126 expression response by semi-quantitative RT-PCR on total RNAs extracted from lung tissue.
127
Quantitative RT-PCR for total FGF18 transcript was performed as described below (primers in table   128   1 were then ranked with respect to their P-value, and the list of features in the best 1% was determined.
161
We computed the mean of the logratios, ranked the features and selected the top 0.5 for each direction 162 of differential expression. The intersection of those 2 lists was selected for further analysis. 
221
Data from RT-qPCR determinations used to confirm expression changes of selected genes and to 222 determine their developmental expression profiles were referred to both 18S rRNA and Hprt1 mRNA.
223
Although absolute values provided by both references were slightly different, they indicated the same 224 proportional changes ( Table 6 ). The use of either reference therefore did not affect conclusions.
225
Because 18S analysis on a larger number of pups indicated even stronger stimulation (almost 6.9-fold, table 7).
236
Adm was followed by CD36 antigen (also known as fatty acid translocase), and hydroxysteroid 11β 237 dehydrogenase 1 (Hsd11b1), which was confirmed by RT-qPCR although changes were found to be 238 slightly (CD36) or largely (Hsd11b1) higher than those detected by microarrays (table 7) . The 239 postnatal expression profiles of these 3 genes in normal lung shared a 2.5-to 5-fold decrease between 240 days P0 and P4 ( Fig. 4) , an event that appeared to have been prevented by FGF18 induction in 241 transgenic pups. This was followed by re-increase from P4 but with different patterns. Adm transcript 242 rose sharply from P4, peaked from P7 to P14, then fell to retrieve low level on P20 onwards ( Fig. 4 ),
243
displaying therefore a profile resembling that of endogenous FGF18 expression, except for the P4 244 decrease. CD36 expression also re-increased rapidly from P4 whereas that of Hsd11b1 re-increased 245 more gradually, but contrary to Adm, both maintained high level until day 28 and returned to low level 246 in adult lung only ( Fig. 4 ). CD36 expression level varied widely among individuals.
247
In addition to fibulin 1 expression already known to be enhanced by FGF18 (7) 
280
Last, in keeping with its effects on lung-fibroblast proliferation (7), FGF18 enhanced the 281 expression of a variety of genes involved in cell growth and ribosome synthesis, including G0G1 282 switch gene 2, brix domain containing 1 (Bxdc1), NIMA-related expressed kinase 8 (Nek8) ( 
369
Limitations of the study.
370
One could raise an objection that lack of morphological changes after precocious induction of FGF18 371 expression argues against the involvement of the factor in alveolarization mechanisms. However, 372 considering the complexity of alveolarization and the multiplicity of involved control factors (5) 
430
FGF18-transgene induction also enhanced expression of other genes likely to be involved in 431 angiogenesis, including Wnt2, a growth and differentiation factor for endothelial cells (22). This is 432 consistent with decreased Wnt2 expression reported in compound FGFR3/4 mutant mice (42).
433
Although more modestly, FGF18 also enhanced the expression of cullin 2 (not shown in 
765
Genes with name and symbol in bold character had changes checked by RT-qPCR. 766 767 
788
Gene symbols: C1qtnf3 = C1q and tumor necrosis factor related protein 3; Crabp1: cellular retinoic acid binding protein 1. 
